Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Type
Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Contains 9 Component(s), Includes Credits Includes a Live Web Event on 02/28/2024 at 1:00 PM (EST)

    This webinar will explore the evolving landscape of pharmaceutical patents, focusing on key issues facing the industry. Topics include emerging jurisprudence concerning induced infringement based on prescribing information, and challenges and strategies related to validity, including written description, enablement, and obviousness. Additionally, speakers will examine the latest USPTO guidance concerning the intersection of inventorship and AI, and delve into issues impacting patent term, in particular double patenting and continuation practice. Finally, panelists will provide an update on issues to be aware of concerning listing patents in FDA’s Orange Book.

    This webinar will explore the evolving landscape of pharmaceutical patents, focusing on key issues facing the industry. Topics include emerging jurisprudence concerning induced infringement based on prescribing information, and challenges and strategies related to validity, including written description, enablement, and obviousness. Additionally, speakers will examine the latest USPTO guidance concerning the intersection of inventorship and AI, and delve into issues impacting patent term, in particular double patenting and continuation practice. Finally, panelists will provide an update on issues to be aware of concerning listing patents in FDA’s Orange Book.

    Renée Fuller

    Senior Corporate Counsel

    Bristol Myers Squibb Company

    Renée Fuller is Senior Corporate Counsel in the Innovation Law Group at BMS and provides strategic counseling on all facets of patent and innovation law. Prior to BMS, Renée worked in-house at MyoKardia, Inc. and in private practice at Wolf, Greenfield & Sacks, where she focused on global patent procurement and strategy, transactions, diligence, and contested matters. Renée earned a B.S. in Chemistry from UNC-Chapel Hill, Ph.D. in Chemistry and Biomedical Engineering from MIT, and J.D. from Suffolk University Law School and completed a postdoctoral fellowship in Chemistry at Harvard University.

    James Sanner

    Senior Associate

    Leydig, Voit & Mayer, Ltd.

    James Sanner is a senior associate at Leydig, Voit & Mayer, Ltd. in Chicago. James focuses his practice on patent litigation, including Hatch-Waxman litigation, and also handles contested proceedings before the Patent Trial and Appeal Board and International Trade Commission. James holds a J.D. from the University of Illinois College of Law, a master's degree in Microbiology and Molecular Genetics from Rutgers University, and a bachelor's degree in Molecular and Cellular Biology from the University of Illinois at Urbana-Champaign.

    Steven H. Sklar

    Shareholder

    Leydig, Voit & Mayer, Ltd.

    Steven H. Sklar is a shareholder with Leydig, Voit & Mayer, Ltd. Steve has more than 27 years of experience representing clients in patent litigation in the pharmaceutical and biotechnology fields, in particular Hatch-Waxman litigation. Steve regularly advises on clients on issues of infringement, validity, and enforcement of pharmaceutical patents.  His many successes include a recent victory, both at trial and on appeal to the Federal Circuit, in litigation involving a leading opioid addiction treatment drug product. Steve graduated magna cum laude with a B.S. in Chemical Engineering from Washington University in St. Louis and earned his law degree cum laude from the Northwestern University School of Law.

  • Contains 9 Component(s), Includes Credits Recorded On: 02/01/2024

    On February 5, an en banc Federal Circuit will consider whether the current design patent obviousness test is overly rigid and should be revised. The Court has issued a series of detailed questions to be considered and this forthcoming decision could fundamentally change the issue of design patent obviousness as well as the perceived value of design patent protection. In preparation for the argument, this webinar will discuss an overview of the issues to be considered, a detailed dive into the United States’ brief and the amicus brief from Apple (both of which are expected to be important to the Court), and consideration of how this decision could affect the design patent obviousness question at the PTAB and the district court level in the future. The panel will also discuss details about what to expect during the oral argument. After the webinar, audience members will be armed with the knowledge they need to get the most out of the upcoming oral argument.

    On February 5, an en banc Federal Circuit will consider whether the current design patent obviousness test is overly rigid and should be revised. The Court has issued a series of detailed questions to be considered and this forthcoming decision could fundamentally change the issue of design patent obviousness as well as the perceived value of design patent protection. In preparation for the argument, this webinar will discuss an overview of the issues to be considered, a detailed dive into the United States’ brief and the amicus brief from Apple (both of which are expected to be important to the Court), and consideration of how this decision could affect the design patent obviousness question at the PTAB and the district court level in the future. The panel will also discuss details about what to expect during the oral argument. After the webinar, audience members will be armed with the knowledge they need to get the most out of the upcoming oral argument.

    Elizabeth Ferrill

    Partner

    Finnegan, Henderson, Farabow, Garrett & Dunner LLP

    Beth Ferrill is a partner in Finnegan’s Washington DC officeShe counsels clients who hold design patents as well as those accused of infringement. Her practice includes prosecution of families of design patents before the USPTO, directing prosecution in foreign countries, arguing appeals before the PTAB, and taking design patent infringement cases through trial in district courtBeth is the recipient of Intellectual Property Owners Association (IPO)’s Carl B. Horton Distinguished Service Award and has been recognized by Intellectual Asset Management Patent 1000 as a leader in patent litigation and transactions in the D.C. area, and nationally for design patents. She is the Editor-in-Chief of Comparative Global Design Law, published by Bloomberg law, leads Finnegan’s veterans pro bono program, and serves as co-chair of Finnegan’s litigation section. 

    Brendan O'Dea

    Partner

    Womble Bond Dickinson

    Brendan O'Dea is a partner at Womble Bond Dickinson with a patent practice focused in the mechanical and electromechanical arts, as well as in industrial designs.  In guiding his clients from their initial concepts to concrete strategies for managing their intellectual property portfolios, Brendan practices at all stages before the U.S. Patent Office, provides legal opinions on patent validity and non-infringement, and advises with regard to commercialization and licensing.  Outside of his work with clients, Brendan teaches a course on patent prosecution in the engineering department at Georgia Tech.  Brendan received his B.S. degree in Mechanical Engineering from Lafayette College and his J.D. degree from Brooklyn Law School. 

    Perry J. Saidman

    Of Counsel

    Saidman DesignLaw Group, LLC

    Perry Saidman is a recognized pioneer in design law. He has more than 40 years of experience providing design protection and enforcement strategiesHis expertise in design patent prosecution issues facilitates resolution of difficult or unusual cases when it comes to enforcement. As a prolific author and speaker, and in his private practice, Perry takes on many seemingly intractable design law issues of the day, including functionality, anticipation, obviousness, infringement and damages. He is very active in bar associations, including the Design Rights Committee of the IPO and AIPLA’s Industrial Designs Committee which he founded in 1989. He has taught Design Law as an adjunct professor at G.W. Law School, and testified before the House Judiciary Committee regarding the auto replacement parts bill. His most recent papers involve the hot button issues of design patent anticipation, the written description requirement under sec. 112, functionality, and determining the article of manufacture under  35  U.S.C.  289.  He also  authors  a  blog  at designlawperspectives.com covering recent design law cases and happenings.

  • Contains 9 Component(s), Includes Credits

    During this webinar, panelists will discuss the guidelines and potential consequences of the proposal. Under Bayh-Dole, universities and other contracting organizations are given rights to intellectual property generated from federally funded research and enabled to license these inventions to private sector partners who can then commercialize them. It includes a “march-in” provision that permits the government, in specific and limited circumstances, to require the patent holder to grant additional licenses to the patented technology.

    The Biden Administration recently unveiled new guidance for exercising march-in rights under the Bayh-Dole Act. Under Bayh-Dole, universities and other contracting organizations are given rights to intellectual property generated from federally funded research and enabled to license these inventions to private sector partners who can then commercialize them. It includes a “march-in” provision that permits the government, in specific and limited circumstances, to require the patent holder to grant additional licenses to the patented technology.

    The proposed framework for the first time includes “reasonableness of the price and other terms at which the product is made available” as a factor agencies can consider. Many in the IP community quickly condemned this proposal as a poison pill for commercializing inventions created through government funded research, hitting universities and startups hardest while also creating problems for companies that traditionally have partnered with those entities to transform early-stage research into commercialized products. Despite the Administration’s linkage of the proposed framework to drug pricing, the proposed guidelines would apply equally to all federal agencies, not just the National Institutes of Health, and thus could affect numerous technology sectors. 

    During this webinar, panelists will discuss the guidelines and potential consequences of the proposal.

    Joseph Allen

    Executive Director

    Bayh-Dole Coalition

    Joseph Allen is Executive Director of the Bayh-Dole Coalition. As a professional staffer on the Senate Judiciary Committee to Sen. Birch Bayh (D-IN), he played a key role in successfully passing the Bayh-Dole Act of 1980 and its subsequent amendments. He later served as the director of the Office of Technology Commercialization at the Department of Commerce, which oversaw the implementation of Bayh-Dole and chaired the Interagency Committee on Technology Transfer.

    Emily Johnson

    Head of IP Policy & Advocacy

    Amgen, Inc.

    Emily Johnson is the Head of IP Policy & Advocacy for Amgen, one of the world’s leading biotechnology companies.  Emily is responsible for influencing the development of sound public policy with respect to IP protections that are important to Amgen’s long-term success. Emily collaborates cross-functionally with Amgen’s IP, litigation, regulatory, antitrust, commercial, and government affairs teams to develop IP policy positions.  She also engages with external trade organizations and government agencies and identifies and develops amicus brief opportunities in cases that raise significant IP issues for Amgen.  Prior to Emily’s policy role, she litigated U.S. and foreign patent disputes, proceedings before the USPTO’s Patent Trial and Appeal Board, and appeals to the Federal Circuit.  Emily had the privilege of clerking for the Honorable Arthur Gajarsa (now retired) at the US Court of Appeals for the Federal Circuit.  Emily chairs the Pharmaceutical & Biotechnology Issues Committee of Intellectual Property Owners Association and serves on the Board of the Federal Circuit Bar Association.     

    Mercedes Meyer

    Attorney

    Banner & Witcoff, Ltd.

    Mercedes K. Meyer, Ph.D., represents leading life science and technology companies maintaining an extensive biotechnology and pharmaceutical patent management, prosecution, opinion and due diligence practice. With a doctorate in virology and degree in chemistry, Mercedes has a deep understanding of complex biotechnology and scientific research, which is key for advising life science clients on commercializing and protecting product innovations as well as performing diligence for investing in new technologies, particularly in corporate joint development projects. Mercedes advises on developing patent strategies, managing the intellectual property rights, and making associated investments and acquisitions. Mercedes also handles patent reexaminations and inter partes matters.

    Corey Salsberg

    Vice President and Global Head of IP Affairs

    Novartis

    Corey Salsberg is Vice President and Global Head of IP Affairs for Novartis, one of the world’s leading biopharmaceutical innovators. He is a globally recognized attorney, strategist and thought leader in the fields of intellectual property (IP) and innovation law and policy. An experienced practitioner and advocate, Corey is a frequent speaker and contributor around the world. His recent engagements include testifying before the United States Senate Judiciary Subcommittee on IP regarding AI and intellectual property (June 2023); public remarks at the USPTO Listening Sessions on AI and Inventorship (April 2023) and USPTO-FDA Collaboration Initiatives (January 2023); testifying before the United States Senate Judiciary Subcommittee on IP on the state of patent eligibility law in the US; public appearances before WIPO, the WHO, and other government and multilateral bodies; and a variety of keynotes and public podcasts. Corey is also proud to be an Officer and Member of the Board of Directors of the Federal Circuit Bar Association, a Member of the Board of Directors of IPO, a Member the Board of Directors of California Lawyers for the Arts, and a founder and member of the Steering Committee of the WIPO-World Economic Forum Inventors Assistance Program. He is featured in the 2021 and 2022 IAM 300, a list of the world's leading IP strategists, and has been named as an IP Corporate Star in Managing IP for each of the last three years.

  • Contains 9 Component(s), Includes Credits Recorded On: 01/24/2024

    A panel of highly experienced patent attorneys from the US, Europe and Japan will discuss recent court decisions on patent enablement, the impact for future decisions, and strategies for addressing enablement in patent applications and litigation. They will provide a brief overview of patent enablement in each country and discuss recent decisions including the US Supreme Court decision in Amgen and the Amgen cases in Europe and Japan. In addition, they will compare and contrast the patent enablement requirements for each country and provide strategies for complying with enablement.

    A panel of highly experienced patent attorneys from the US, Europe and Japan will discuss recent court decisions on patent enablement, the impact for future decisions, and strategies for addressing enablement in patent applications and litigation. They will provide a brief overview of patent enablement in each country and discuss recent decisions including the US Supreme Court decision in Amgen and the Amgen cases in Europe and Japan. In addition, they will compare and contrast the patent enablement requirements for each country and provide strategies for complying with enablement.

    John Augustyn

    Shareholder

    Leydig, Voit & Mayer, Ltd.

    John Augustyn is a shareholder in Leydig’s Chicago office.  He successfully represents clients in high stakes litigation, opinions, licensing, due diligence, and prosecution. In the Amgen, Inc. v. Sanofi case at the US Supreme Court.  John was Counsel for Amicus Curiae, Intellectual Property Law Association of Chicago (IPLAC).  He has provided over 30 CLE seminars for attorneys, has authored numerous articles and chapters for books, and has appeared on multiple television and radio programs.  In the evenings, John has taught several law school courses.  Prior to attending law school, he worked in engineering and management at two Fortune 100 companies.  John has received several honors including Best Lawyers, Super lawyers, IAM Patent 1000, and Fellow of Litigation Counsel of America.  For more info, see https://www.leydig.com/professionals/john-augustyn/

    Cass Dottridge

    In-House Counsel

    Cargill, Inc.

    Cass Dottridge has more than twenty-five years’ experience in intellectual property, with qualifications to practice in three jurisdictions (the UK, Europe and the US). She worked as an Examiner in the UK, and as an attorney in private practice, before moving to Belgium to join global food company Cargill as in-house counsel. She is now part of the IP Leadership Team for Cargill based in Minneapolis, where she works closely with both business and R&D leaders to drive growth though innovation. She was recently appointed co-chair of the IPO’s European Practice Committee.

    Toshinao Yamazaki

    Group Leader for Corporate Group IP Department

    Sumitomo Chemical

    Toshinao Yamazaki has had a long, successful career in IP, starting in 1999 as Patent Examiner in the field of chemistry at the JPO; the International Division of JPO as a coordinator, responsible for Japan US EP Trilateral Cooperation and IP 5; Visiting Researcher at Department of Aerospace Engineering of UCLA; Japan External Trade Organization (at Dusseldorf office in Germany); International Policy Division of JPO, as a negotiator, responsible for EPA; Deputy Director in Policy Planning and Research Division of JPO; Administrative judge in 25 the department (of Board of Appeal of JPO); Director in Information Technology Management Department of JPO; Director in International Policy Division of JPO, responsible for EPA, WTO and WIPO; Director in Information Economy Division of Ministry of Economy, Trade and Industry and currently is with the Intellectual Property Department of Sumitomo Chemical.

  • Contains 9 Component(s), Includes Credits

    It seems like every court and tribunal was active in altering the intellectual property landscape in 2023. The Supreme Court left its mark in patents, trademarks, and copyright in four important decisions. The Federal Circuit issued any number of informative and at times controversial opinions. The PTAB and TTAB were busy beavers and let’s not forget the regional circuits and their impact on trademarks and copyrights. Our panelists will attempt to distill down the past year’s major decisions and discuss the ones that will affect IP practitioners in 2024 and beyond.

    It seems like every court and tribunal was active in altering the intellectual property landscape in 2023. The Supreme Court left its mark in patents, trademarks, and copyright in four important decisions. The Federal Circuit issued any number of informative and at times controversial opinions. The PTAB and TTAB were busy beavers and let’s not forget the regional circuits and their impact on trademarks and copyrights. Our panelists will attempt to distill down the past year’s major decisions and discuss the ones that will affect IP practitioners in 2024 and beyond.

    Paul Berghoff

    Founder

    McDonnell Boehnen Hulbert & Berghoff LLP

    Paul Berghoff, founder of McDonnell Boehnen Hulbert Berghoff LLP, has three decades of experience as lead trial counsel in complex patent litigation – both jury and bench trials and PTAB proceedings – concentrating in litigation involving pharmaceuticals, medical devices, biotechnology, electronics, and software. He has successfully tried scores of patent cases and has successfully argued dozens of times before he US Court of Appeals for the Federal Circuit. He services as Chair of the firm’s Litigation & Appeals Practice Group. He is Vice-Chair of IPO’s Amicus Brief Committee.

    Gregory Castanias

    Partner

    Jones Day

    Greg Castanias is a partner at Jones Day in Washington, DC. He is head of the firm’s Federal Circuit team and has almost 30 years’ experience as a leading appellate and intellectual property litigator. His experience includes five US Supreme Court arguments, 70+ Federal Circuit arguments, and countless others in federal and state courts across the nation, from Alaska to Connecticut. His intellectual property experience includes such diverse technologies as genetics, diagnostics, pharmaceuticals, chemistry, electronics, and mechanical fields, as well as copyright, trademark, and trade secret disputes. He is Vice-Chair of IPO’s Amicus Brief Committee.

    Wendy Larson

    Member

    Pirkey Barber

    Wendy Larson practices trademark law with a focus on litigation. She focuses specifically on issues relating to the internet, including cybersquatting and brand protection challenges involving social media platforms and smartphone applications, keyword advertising, service provider liability, and personal jurisdiction relating to foreign online actors. She practices in federal court, before the Patent and Trademark Office’s Trademark Trial and Appeal Board (TTAB), and with dispute resolution service providers such as the Forum and the World Intellectual Property Organization (WIPO) handling domain name disputes under ICANN’s domain name dispute resolution policies. Wendy also assists clients in a variety of prosecution and other litigation matters. Wendy is a member of IPO’s Amicus Brief Committee.

  • Contains 9 Component(s), Includes Credits

    A panel of highly experienced PTAB advocates will discuss some of the most significant developments in PTAB practice in 2023 and how those developments will impact future cases. They will discuss important decisions promulgated last year, including several designated precedential, as well as court treatment of PTAB decisions with implications for PTAB practice. In this discussion, you will hear what you need to know to keep your PTAB practice sharp in 2024.

    A panel of highly experienced PTAB advocates will discuss some of the most significant developments in PTAB practice in 2023 and how those developments will impact future cases. They will discuss important decisions promulgated last year, including several designated precedential, as well as court treatment of PTAB decisions with implications for PTAB practice. In this discussion, you will hear what you need to know to keep your PTAB practice sharp in 2024.

    Sendil Devadas

    Assistant Chief IP Counsel

    Corteva Agriscience

    Sendil Devadas is passionate about creating IP strategy road maps for difficult to spot trends in a variety of technology areas. He builds and develops collaborative teams to execute IP strategy. Sendil received his Ph.D. from Penn State University and attended University of Illinois Chicago Law School where he graduated Cum Laude.

    Kassandra Officer

    Partner

    Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

    Kassandra Officer focuses on patent and trade secret litigation before U.S. district courts as well as on post-grant proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO). Her practice encompasses a range of technologies, with an emphasis on chemicals, pharmaceuticals, and medical devices.

    Joshua Goldberg

    Partner

    Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

    Joshua Goldberg, leader of Finnegan’s PTAB trials section, focuses on inter partes review (IPR), covered business method (CBM), and post-grant review (PGR) proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO), and on ensuing appeals to the U.S. Court of Appeals for the Federal Circuit.

  • Contains 6 Component(s), Includes Credits

    This session will consider laws – such as the EU AI Act, EU Data Act, right to repair laws, TRIPS/WTO IP waiver, and privacy laws – that could compel owners of trade secrets to provide the otherwise secret information to governments, consumers and competing companies. Speakers will discuss increasingly restrictive government policies that limit the flow of information to certain nations (e.g., Chips and Science Act), and efforts to use trade laws and other mechanisms to penalize trade secret theft (e.g., Protecting Intellectual Property Act of 2022). In addition, this panel will also address the push in the US to reduce employee non-compete restrictions, which have the goal of increasing employee mobility but which make it harder for companies to protect trade secrets.

    With proprietary information continuing to grow in importance and value as an asset across the world, trade secrets have recently been the focus of new enacted and proposed laws and regulations. This session will consider laws – such as the EU AI Act, EU Data Act, right to repair laws, TRIPS/WTO IP waiver, and privacy laws – that could compel owners of trade secrets to provide the otherwise secret information to governments, consumers and competing companies. Speakers will discuss increasingly restrictive government policies that limit the flow of information to certain nations (e.g., Chips and Science Act), and efforts to use trade laws and other mechanisms to penalize trade secret theft (e.g., Protecting Intellectual Property Act of 2022). In addition, this panel will also address the push in the US to reduce employee non-compete restrictions, which have the goal of increasing employee mobility but which make it harder for companies to protect trade secrets.

    Kenneth Corsello

    Trade Secrets Counsel

    IBM Corp.

    Ken Corsello is IBM’s U.S. Trade Secrets CounselHe is a member of IPO’s Trade Secrets committee, which he chaired from 2016 to 2021, and a member of the Standards Setting committee and IP Licensing and Related Issues committeeKen is a frequent speaker on Trade Secrets topics and in 2018 he testified on behalf of IPO about the Defend Trade Secrets Act at a hearing of the U.S. House of Representatives, Commerce Committee, Subcom. on Courts, Intellectual Property & the Internet. During his 17 years at IBM, Ken’s work has included patent procurement, litigation, client counseling, product clearance, and transactional matters. Before joining IBM, he was a law clerk to Chief Judge Glenn Archer at the Federal Circuit; an Associate Solicitor in the USPTO; and in private practice at law firms in Washington, D.C.   

    Dawn Mertineit

    Partner

    Seyfarth Shaw LLP

    Dawn Mertineit is a Partner at Seyfarth Shaw LLP. For more than a decade, Dawn has represented corporations and their directors and officers in a number of industries in complex commercial litigation, litigating partnership, franchise, real estate, and whistleblower disputes, with a special emphasis on noncompete and trade secrets litigation. She understands that many clients rely on noncompete and nonsolicitation agreements to protect their most valuable assets, while others face hurdles in recruiting and onboarding new employees bound by such restrictive covenants. Dawn brings her experience and knowledge of state and federal laws to help her clients navigate these issues, from drafting agreements and executing rollout and enforcement strategies, to analyzing competitor agreements and proposing recruitment and onboarding plans, and prosecuting or defending against claims related to misappropriation of trade secrets or breach of restrictive covenants.

    Thomas Valente

    Senior Director for Global Affairs

    Intellectual Property Owners Association

    Thomas S. Valente is the Senior Director for Global Affairs at the Intellectual Property Owners Association (IPO) in Washington, DC. IPO is an international trade association representing companies and individuals in all industries and fields of technology who own, or are interested in, intellectual property rightsMr. Valente is the IPO staff lead on international IP mattersDuring his career, he has also practiced with law firms, both big and small, covering a wide range of IP issuesHe is a graduate of the University of Virginia School of Law and served as a law clerk for the Honorable Peter W. Hall of the U.S. Court of Appeals for the Second Circuit.

  • Contains 5 Component(s), Includes Credits

    In this webinar, we will discuss the disparity in demographics of inventors, an overview of the Patent Pro Bono Program and its impact on inventor demographics, as well many other opportunities for low-resourced inventors through the USPTO’s Council on Inclusive Innovation and other programs. Patent Pro Bono Volunteers can share their skills and talents for intellectual property protection, while knowing that their clients have access to many resources for commercializing their invention.

    The demographics of inventors on USPTO issued patents does not match the demographics of the United States population. This is true whether considering gender, race, ethnicity, or economic status. The Intellectual Property community through associations like IPO, the USPTO, Bar Associations, Universities, and others are working to make access to the patent system more inclusive. Participation in the Patent Pro Bono Program is a way to make a concrete impact on access to the patent system for low-resource inventors that allows Patent Attorneys to use their unique skill sets to satisfy their pro bono responsibilities. We will discuss the disparity in demographics of inventors, an overview of the Patent Pro Bono Program and its impact on inventor demographics, as well many other opportunities for low-resourced inventors through the USPTO’s Council on Inclusive Innovation and other programs. Patent Pro Bono Volunteers can share their skills and talents for intellectual property protection, while knowing that their clients have access to many resources for commercializing their invention.

    Grant Corboy

    Staff Attorney - Patent Pro Bono Program Administrator - Office of Enrollment and Discipline

    USPTO

    Grant Corboy joined the Office of Enrollment Discipline (OED)as a Patent Attorney in 2016. As a member of the Patent Pro Bono Team, he is dedicated to making sure that all inventors have access to the patent system, including those who are financially under-resourced. In addition to his Patent Pro Bono responsibilities, Mr. Corboy also serves as a Staff Attorney investigating discipline and enrollment matters. Mr. Corboy was a Primary Patent Examiner for the United States Patent and Trademark Office (USPTO) and, prior to joining the USPTO in 2010, he worked for fifteen years in industry as a design engineer, project manager and government contracts manager with DuPont and Lockheed Martin. Mr. Corboy is a member of the Maryland bar, and he is registered to practice before the USPTO. He graduated, cum laude, from The University of Baltimore School of Law and received a Bachelor of Science in Mechanical Engineering and his Masters of Science in Structural Engineering from the University of Delaware.

    Jennifer Knight

    Attorney and Of Counsel

    Clements Bernard Walker (CBW)

    Dr. Jennifer Knight joined Clements Bernard Walker (CBW) as Of Counsel in 2018. Prior to joining CBW, Jennifer managed a solo law practice for two years after completing a successful thirty-year career with Eastman Chemical Company. While at Eastman Chemical, Jennifer spent seventeen years in various technical and managerial roles, three years in law school and law internships, and ten years as Intellectual Property Council. Jennifer is a member of the Tennessee and North Carolina bars, and she is registered to practice before the USPTO. She graduated summa cum laude from the University of Tennessee College of Law, earned a Bachelor of Science in Chemical Engineering at the University of Tennessee, and a Doctor of Philosophy in Chemical Engineering from the University of Massachusetts. She is also a Patent Pro Bono volunteer and Patent Pro Bono Co-chair for the North Carolina Bar Association, Intellectual Property Law Section. Jennifer lives in Charlotte with her husband and in close proximity to six grand people (ages 3 to 7) and their parents.

    Sandra Nowak

    Associate Chief IP Counsel - 3M’s Health Care Business Group

    3M Innovative Properties Co.

    Sandra Nowak is Associate Chief IP Counsel of 3M’s Health Care Business Group, which connects people, insights, science, and technology to solve problems and make better health possible. Since joining 3M in 2005, Ms. Nowak held positions of increasing responsibility within the 3M Legal Affairs Department.  In her various roles, Ms. Nowak has worked on various patent, trademark, domain name, and trade secret litigation matters; negotiated numerous global IP agreements; and has filed and/or prosecuted over a hundred patent applications.  Ms. Nowak began her legal career as an IP attorney with Stoel Rives LLP in Portland, Oregon. Prior to law school, Ms. Nowak performed chemical research for the United States Department of Agriculture.  Ms. Nowak has a JD from the University of Oregon law school and a BA (Chemistry) from Franklin and Marshall College. Ms. Nowak is also passionate about diversity in innovation.  She helps lead this effort at 3M and around the world in her role as co-chair of the Intellectual Property Owners Association’s (IPO’s) Women in IP Committee and Diverse Inventors Subcommittee, where she works with a global group of IP professionals and inventors to advance diversity in the legal profession and in the innovation ecosphere. In April 2019, Ms. Nowak testified before the United States Senate Judiciary Committee on the topic of Trailblazers and Lost Einsteins: Women Inventors and the Future of American Innovation.

    Warren Tuttle

    Open Innovation Director & Author

    Tuttle Innovation

    Warren Tuttle has for many years overseen the Open Innovation product programs for several industry leading companies including publicly traded Lifetime Brands in the housewares and tabletop arenas (Farberware, Kitchen Aid and 40 other brands), Techtronics Industries Power Tool Group in the power tool and hardware industries (Ryobi, Rigid, Hart Tools and other brands) and Merchant Media in the Direct Response Television category (True Touch and other brands). He was also the person behind the launch of several highly successful consumer products including MISTO, The Gourmet Olive Oil Sprayer and the SmartSpin Storage Container System. Currently Warren is the Open Innovation Director for MarketBlast, the premier platform for innovators submitting new, unique & innovative products directly to leading companies. Warren personally interacts with thousands of inventors every year and has initiated well over 100 new consumer product licensing agreements that have collectively generated more than a billion dollars in retail sales. Warren is also a well-known advocate for inventor rights. He served for 12 years as the President of the United Inventors Association Board of Directors, a national 501c3 non-profit with high ethical standards that helps inventors through education, advocacy and the sponsorship of inventor booth pavilions at industry trade shows such as the National Hardware and Housewares Shows. Warren is also a member of the National Pro Bono Patent Council (PBAC) and the Department of Commerce Council for Innovation Inclusion (CI2). He also co-chairs the Creator Committee for the US Intellectual Property Alliance (USIPA). Warren’s book, Inventor Confidential: The Honest Guide to Profitable Innovation, is published by Harper Collins and available on Amazon. He lives with his wife Lynn in Southern Connecticut and has three wonderful daughters, all well-educated and pursuing inspiring careers. He enjoys skiing, motorcycling, golf and travel. Please visit Warren’s website www.tuttleinnovation.com or email him at wwtuttle@yahoo.com.

  • Contains 6 Component(s), Includes Credits

    Come listen to a lively discussion between a designer, a seasoned litigator and design patent prosecutor as they explore and consider various aspects of industrial design law including the ordinary observer, obviousness, indefiniteness, and the impact of other legal interpretations on industrial design rights. Hear the panel speak to how the law can advance the work of the industrial designer whose manufactured product is shaped to fit the people who use it as well as the processes that produce it – while striving to provide a distinctive elegance that attracts consumers to buy it.

    Ever wonder about the designer’s perspective on protection and enforcement of his/her design rights? If so, this webinar is perfect for you. Come listen to a lively discussion between a designer, a seasoned litigator and design patent prosecutor as they explore and consider various aspects of industrial design law including the ordinary observer, obviousness, indefiniteness, and the impact of other legal interpretations on industrial design rights. Hear the panel speak to how the law can advance the work of the industrial designer whose manufactured product is shaped to fit the people who use it as well as the processes that produce it – while striving to provide a distinctive elegance that attracts consumers to buy it.

    Tim Fletcher

    President

    One BusinessDesign, LLC

    Tim Fletcher is an experienced expert witness in design patent, utility patent and trade dress cases. Venues include Federal Court, The International Trade Commission and the PTAB. With over 33 years of experience in industrial design, he has worked in corporate, consulting and academic environments in the US as well as internationally. He has been working with manufactures and clients in Asia and Europe since 1989. He holds 14 design patents and 4 utility patents in the US and Europe. He was an Assistant Professor at the School of Design at The Hong Kong Polytechnic University and also has taught design topics in several schools at Carnegie Mellon University. Tim has been a member of the Industrial Designers Society of America since 1989. He has worked in several elected and appointed positions within the organization. In 2009 he was inducted into the IDSA Academy of Fellows, the highest honor bestowed by the organization.

    Anthony Prenol

    Founding Partner

    CPST Intellectual Property

    Anthony Prenol is a founding partner of CPST Law LLP and its related patent and trademark agency firm, CPST Intellectual Property Inc. He is a lawyer, patent agent and trademark agent. Anthony's practice covers the full range of intellectual property protection, enforcement and commercialization. He has acted as trial and appellate counsel in a wide variety of patent, trademark and copyright litigation matters. Anthony is responsible for the prosecution of patent, trademark and industrial design portfolios for clients in a wide variety of industries. In particular, he has extensive experience in the energy and financial services sectors. He regularly advises clients in areas such as trademark clearance, freedom-to-operate opinions, data protection for innovative drugs, comparative advertising, official marks, and matters arising under the Patented Medicines (Notice of Compliance) Regulations.

    Richard Stockton

    Attorney

    Banner & Witcoff, Ltd.

    Richard S. Stockton advises clients on all aspects of intellectual property law, including tactical and strategic counseling, portfolio management, litigation and prosecution matters. Richard earned a Bachelor of Science degree in Electrical Engineering from the University of Illinois at Urbana-Champaign (UI) in 1997. He graduated from the UI College of Law cum laude in 2000. Richard also has governmental relations and policy experience. He has prepared draft legislation, and served as a legislative extern to the Illinois House of Representatives. Richard also interned in Congress.

    Mina Stricklin

    Senior Counsel (Senior Director) - Design Patents

    Nike, Inc.

    Mina Stricklin is an experienced Assistant General Counsel with a 20+ year demonstrated history of in-house multifaceted patent practice in the consumer products industry. She is currently living the dream in Portland, OR while managing the patent team responsible for global protection of Nike's innovative product designs. Mina attended the University of Dayton where she received her B.S., Environmental/Chemical Engineering Tech and received her law degree from the University of Cincinnati College of Law.

  • Contains 9 Component(s), Includes Credits

    This webinar will address Third-Party Preissuance Submissions under 35 U.S.C. 122(e) and how they can be strategically employed to curtail the issuance of overly broad US Patents. A case for when and how to take advantage of the power to participate in the patent prosecution of competitors will be laid out. Benefits vs. drawbacks and potential pitfalls will be outlined. Finally, a model third-party submission regime will be proposed, including publication monitoring, prior art development, and strategic drafting of third party submissions with be detailed. Presenters will include both in house and law firm counsel with extensive third-party submission experience to provide a diverse set of perspectives.

    This webinar will address Third-Party Preissuance Submissions under 35 U.S.C. 122(e) and how they can be strategically employed to curtail the issuance of overly broad US Patents. A case for when and how to take advantage of the power to participate in the patent prosecution of competitors will be laid out. Benefits vs. drawbacks and potential pitfalls will be outlined. Finally, a model third-party submission regime will be proposed, including publication monitoring, prior art development, and strategic drafting of third party submissions with be detailed. Presenters will include both in house and law firm counsel with extensive third-party submission experience to provide a diverse set of perspectives.

    Michael Burleigh

    Patent Attorney

    Leydig, Voit & Mayer, Ltd.

    Michael Burleigh is a patent attorney in Leydig’s Boulder office whose practice focuses primarily on patent prosecution, due diligence and trademark matters. His diverse range of patent prosecution experience encompasses materials science, chemistry, biotechnology, computer science, and mechanical engineering. His prior career as a process engineer in the pharmaceutical industry informs his legal approach and grounds him technically.

    Nathan Frederick

    Director, IP Services

    Cardinal Intellectual Property

    Nathan Frederick is the Director of IP Services for Cardinal Intellectual Property. Within this role, he manages Cardinal's corporate and law firm accounts. His concentration focuses on IP search, e-discovery, valuation, monetization, and competitive monitoring of products and services. He received his Bachelor of Science, Electrical Engineering from Valparaiso University and his law degree at the University of Iowa.

    Dimitry Kapmar

    Director Counsel, Patent Operations

    Zebra Technologies Corporation

    Dimitry Kapmar is an Intellectual Property attorney with an emphasis on patent portfolio management and patent litigation. He also has extensive prior engineering experience in the wireless telecommunications arena. His specialties include patent portfolio management, patent litigation, patent opinions and due diligence, patent prosecution, and trademark counseling. He received his B.S., Electrical Engineering from the Illinois Institute of Technology and his law degree from the University of Illinois Chicago School of Law.